Active management of the premature membrane rupture in pregnancies of 34 to 37 weeks;Manejo activo de la rotura prematura de membranas en embarazos de 34 a 37 semanas

Ginecologia y Obstetricia de Mexico

Volumn 74, Issue 5, 2006, Pages 252-259

  Martínez, María Guadalupe Veloz ^a   Baños, Jorge Bolaños ^a   Ibarra, María De Los Ángeles Guzmán ^a   Rodríguez, Oscar Arturo Martínez ^a   Angulo, José Antonio Páez ^a   Valencia, Marcelino Hernández ^a  

^a INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

Author keywords

Fetal morbidity; Maternal morbidity; Membrane rupture

Indexed keywords

ADULT; ARTICLE; CESAREAN SECTION; CONTROLLED STUDY; FEMALE; FETUS; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MATERNAL MORBIDITY; PREGNANCY; PREGNANCY COMPLICATION; PREMATURE FETUS MEMBRANE RUPTURE; STATISTICAL ANALYSIS; CASE CONTROL STUDY; THIRD TRIMESTER PREGNANCY;

ADULT; CASE-CONTROL STUDIES; FEMALE; FETAL MEMBRANES, PREMATURE RUPTURE; HUMANS; PREGNANCY; PREGNANCY TRIMESTER, THIRD;

EID: 35348832922     PISSN: 03009041     EISSN: 03009041     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Nava FJ, Enríquez MC, Hernández-Valencia M. Condiciones atribuibles y costos de la morbilidad materno-fetal en pacientes con ruptura prematura de membranas después de las 27 semanas de gestación. Ginecol Obstet Mex 2003;71:343-8.
2. Beltrán MJ, Ávila VMA, Vadillo OF, Hernández GC. Infección cervicovaginal como un factor de riesgo para trabajo pretérmino. Ginecol Obstet Mex 2002;70:203-9.
3. Vadillo OF, Gonzalez AG, Karchmer S. Collagen metabolism in premature rupture of amniotic membranes. Obstet Gynecol 1990;75:84-88.
4. O'Brien WF, Knuppel RA, Morales WJ. Amniotic fluid alpha-antitrypsin concentration in premature rupture of the membranes. Am J Obstet Gynecol 1990;162:756-9.
5. Harger JH, Hsing AW, Tuomala RE. Risk factors for preterm premature rupture of fetal membranes: a multicenter case-control study. Am J Obstet Gynecol 1990;163:130-5.
6. Romero R, Durum S, Dinarello CA. Interleukin-1 stimulates prostaglandin biosynthesis by human amnion. Prostaglandins 1989;37:13-18.
7. Kaye D. Risk factors for preterm premature rupture of membranes at Mulago Hospital, Kampala. East Afr Med J 2001;78:65-69.
8. Locksmith G, Duff P. Infection, antibiotics, and preterm delivery. Semin Perinatol 2001;25:295-309.
9. Romero R, Quintero R, Ayarzun E. Intra-amniotic infection and the onset of labor in preterm premature rupture of the membranes. Am J Obstet Gynecol 1988;159:661-8.
10. Medina TM, Hill DA. Preterm premature rupture of membranes: diagnosis and management. Am Fam Physician 2006;73:659-64.
11. Jahromi N, Ardekany M, Poorarian S. Relationship between duration of preterm premature rupture of membranes and pulmonary maduration. Int J Gynaecol Obstet 2000;68:119-22.
12. Hernández-Valencia M. Cervical ripening with prostaglandin E1: how an ambulatory method decreases the hospital stay in abortus with intrauterine fetal demise. Fetal Diagn Ther 2002;94:1-9.
13. Schoonmaker JN, Lawellin DW, Lunt B. Bacteria and inflammatory cells reduce chorioamnioitic membrane integrity and tensile strength. Obstet Gynecol 1989;74:590-96.
14. Nicolini U, Fisk NM, Rodeck CH. Low amniotic pressure in oligohydramnios, is this the cause of pulmonary hypoplasia? Am J Obstet Gynecol 1989;161:1089-94.